)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
NeuroMetrix (NURO) investor relations material
NeuroMetrix Q3 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2024 earnings summary5 Nov, 2024
Executive summary
Q3 2024 revenue declined 51% year-over-year to $0.6M, mainly due to lower DPNCheck sales from adverse Medicare Advantage reimbursement changes and international distributor inventory issues, with Quell sales providing a minor offset.
Net loss for Q3 2024 was $1.5M ($0.75/share), improved from $1.8M ($1.66/share) in Q3 2023, as operating expenses fell 25% year-over-year due to headcount reduction and cost-cutting measures.
Gross profit dropped 60% year-over-year, with gross margin contracting to 53.1% from 65.0%, reflecting lower DPNCheck sales and product mix.
The company is conducting a strategic review, including potential asset sales, mergers, or changes in marketing, with no set timetable for completion.
Company is actively reviewing strategic alternatives to enhance shareholder value.
Financial highlights
Q3 2024 revenue: $0.6M (down 51% year-over-year); nine months ended September 30, 2024: $2.5M (down 47%).
Q3 2024 gross profit: $0.3M (down 60% year-over-year); gross margin 53.1% vs. 65.0% prior year.
Q3 2024 operating expenses: $2.1M (down 25% year-over-year); nine months: $8.1M (down 3%).
Q3 2024 net loss: $1.5M; nine months: $6.0M (vs. $4.9M prior year).
Cash, cash equivalents, and marketable securities at September 30, 2024: $14.8M; working capital: $15.6M; no debt.
Outlook and guidance
Management expects current cash and securities to fund operations for at least the next twelve months.
DPNCheck Medicare Advantage sales are unlikely to recover near-term due to ongoing CMS reimbursement changes; international DPNCheck sales expected to resume in early 2025 as distributor inventory normalizes.
Quell Rx for fibromyalgia is in controlled launch; De Novo application for Quell-CIPN planned for late 2024 or early 2025.
Company continues to pursue opportunities in alternative markets for DPNCheck.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
NeuroMetrix Inc. is a commercial-stage healthcare company that develops diagnostic and therapeutic neurostimulation devices. Its products target chronic pain conditions and neuropathies, incorporating digital health technologies for remote monitoring and personalized treatment. The company serves healthcare professionals and patients through direct and distributor-based sales. The company is headquartered in Woburn, Massachusetts, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage